MMM
28
-2
XYL
35
2
HPQ
52
3
PNR
65
3
AXP
60
-3
KR
38
-2
EA
59
5
DAL
77
-3
WY
56
3
CMCSA
59
6
CMA
50
-2
UNH
50
-5
VFC
65
2
WEC
41
-4
AMAT
40
-3
BK
66
-3
NAVI
43
16
KMB
28
-5
KMX
47
4
BXP
47
3
MMM
28
-2
XYL
35
2
HPQ
52
3
PNR
65
3
AXP
60
-3
KR
38
-2
EA
59
5
DAL
77
-3
WY
56
3
CMCSA
59
6
CMA
50
-2
UNH
50
-5
VFC
65
2
WEC
41
-4
AMAT
40
-3
BK
66
-3
NAVI
43
16
KMB
28
-5
KMX
47
4
BXP
47
3
Financhill
Back

Schwab Intermediate-Term US Trs ETF™ Vs. Viking Therapeutics Industry Stock Comparison

Sell
3

SCHR
Schwab Intermediate-Term US Trs ETF™

Last Price:
24.53
Seasonality Move:
-0.08%
Sell
45

VKTX
Viking Therapeutics

Last Price:
64.63
Seasonality Move:
38.04%
Sell
3
Schwab Intermediate-Term US Trs ETF™ (SCHR) is a Sell

Is Schwab Intermediate-Term US Trs ETF™ a Buy, Sell or Hold?

  • The current Schwab Intermediate-Term US Trs ETF™ [SCHR] share price is $24.54. The Score for SCHR is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • SCHR is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
45
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCHR Stock Price Chart

What is Schwab Intermediate-Term US Trs ETF™'s stock price today?

  • The Schwab Intermediate-Term US Trs ETF™ share price today is $24.54
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCHR is experiencing slight buying pressure.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $63.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

SCHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.15 Sell
Relative Strength Index (14 RSI): 30.59 Sell
Chaikin Money Flow: 1593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.63 - 25.03) Sell
Bollinger Bands (100): (24.55 - 25.23) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 44.37 Sell
Chaikin Money Flow: -27799915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.04 - 71.46) Sell
Bollinger Bands (100): (52.9 - 66.58) Buy

SCHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.63 Sell
20-day SMA: 24.76 Sell
50-day SMA: 25.07 Sell
200-day SMA: 24.61 Sell
8-day EMA: 24.62 Sell
20-day EMA: 24.76 Sell
50-day EMA: 24.9 Sell
200-day EMA: 24.72 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.43 Sell
20-day SMA: 67.48 Sell
50-day SMA: 64.43 Sell
200-day SMA: 59.82 Buy
8-day EMA: 69.69 Sell
20-day EMA: 68.14 Sell
50-day EMA: 65.07 Sell
200-day EMA: 55.33 Buy

Schwab Intermediate-Term US Trs ETF™ Earnings Growth & SCHR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

Schwab Intermediate-Term US Trs ETF™ Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):